Photodynamic therapy with verteporfin vs photodynamic therapy with 5% dextrose
Adverse effects: acute severe visual acuity decrease · people with neovascular age‐related macular degeneration
Photodynamic therapy with verteporfin showed no clear difference in adverse effects: acute severe visual acuity decrease compared with photodynamic therapy with 5% dextrose (moderate certainty).
1 finding from 1 review
- Photodynamic therapy for neovascular age‐related macular degeneration 2007 · Cochrane Headline outcomes onlyRR 3.75 [0.87, 16.12]3 studies · 1075 participantsModerate